Skip to main content
. 2023 Aug 17;9(3):e003250. doi: 10.1136/rmdopen-2023-003250

Figure 1.

Figure 1

Presence of select Elixhauser Comorbidity Index diagnoses during the 12-month baseline period among patients with SLE with and without severe COVID-19. *Significantly different from patients without severe COVID-19 (p<0.05). See online supplemental table 1 for frequency of all Elixhauser Comorbidity Index diagnoses among patients with SLE with and without severe COVID-19. SLE, systemic lupus erythematosus.